Plasminogen activators and inhibitors, D-dimer and β-TG in systemic lupus erythematosus pregnancy in relation to their obstetric outcome

References

• Abramowsky C. R., Vegas M. E., Swinehart G., Gyves M. T. Decidual vasculopathy of the placenta in lupus erythematosus. New England Journal of Medicine 1980; 303: 668–472
   PubMed Web of Science ®Google Scholar
• Abramowsky C. R. Lupus erythematosus, the placenta and pregnancy: a natural experiment in immunologically mediated reproductive failure. Progress in Clinical Biological Research 1981; 70: 309–320
   Google Scholar
• Astedt B., Lecander I., Brodin T., Lundblad A., Low K. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasmin pIasminogen activator. Thrombosis and Haemostasis 1985; 53: 122–125
   PubMed Web of Science ®Google Scholar
• Boey M. L., Colaco C. B., Gharavi A. E., Elkon K. B., Loizou S., Hughes G.R.V. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. British Medical Journal 1983; 287: 1021–1023
   PubMed Web of Science ®Google Scholar
• De Wolf F., Cameras L. O., Moermann P., Vermylen J., von Assche A., Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss and a lupus anticoagulant. American Journal of Obstetrics & Gynecology 1982; 142: 829–834
   PubMed Web of Science ®Google Scholar
• Firkin B.N.G., Howard M. A., Radford N. Possible relationship between lupus inhibitor and recurrent abortion in young women. Lancet 1980; 2: 366
   PubMedGoogle Scholar
• Francis R. B., McGehee W. G., Feinstein D. I. Endothelial dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis. Thrombosis and Haemostasis 1988; 59: 412–414
   PubMedGoogle Scholar
• Gladman D. D., Urowitz M. B., Tozman E. C., Glynn M. F. Haemostatic abnormalities in systemic lupus erythematosus. Quarterly Journal of Medicine 1983; 52: 424–433
   Google Scholar
• Hanly J. G., Gladman D. D., Rose T. H., Laskin C. A., Urowitz M. B. Lupus pregnancy. A prospective study of placental changes. Arthritis and Rheumatism 1988; 31: 358–366
   PubMed Web of Science ®Google Scholar
• Hughes G.R.V. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. British Medical Journal 1983; 287: 1088–1089
   PubMed Web of Science ®Google Scholar
• Juhan–Vague I., Aillaud M. F., De Cock F., Philip–Joet C., Arnaud C., Serradimigni A., Collen D. The fast acting inhibitor of tissue-type plasminogen activator is an acute phase reactant protein. Progress in Fibrinolysis, J. F. Davidson, M. B. Donati, S. Coccheri. Churchill Livingstone, Edinburgh 1985; volume 7: 146–149
   Google Scholar
• Juhan–Vague I., Valadier J., Alessi M. C., Aillaud M. F., Ausaldi J., Philip–Joet C., Holvoet P., Serradimigni A., Collen D. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thrombosis and Huemostasis 1987; 57: 67–72
   PubMed Web of Science ®Google Scholar
• Koh C.L.S., Yuen R., Viegas O.A.C., Chua S. E., Ng B. L., Sen D. K., Ratnam S. S. A plasmin generation method for the determination of tissue plasminogen activator (t-PA) activity in blood. Immunology and Cell Biology 1989a; 67: 197–203
   Google Scholar
• Koh C.L.S., Yuen R., Viegas O.A.C., Chua S. E., Ng B. L., Sen D. K., Ratnam S. S. Plasma tissue plasminogen activator inhibitor (t-PAI) activity in normal subjects. Medical Science Research 1989b; 17: 135–136
   Google Scholar
• Koh C.L.S., Viegas O.A.C., Yuen R., Chua S. E., Ng B. L., Ratnam S. S. Plasminogen activators and inhibitors in normal late pregnancy, postpartum and in the postnatal period. International Journal of Gynaecology and Obstetrics 1992a; 38: 9–18
   Google Scholar
• Koh S.C.L., Yuen R., Viegas O.A.C., Ratnam S. S. Plasma urokinase activity and antigen levels in normal males, females and in fate pregnancy. Medical Science Research 1992b; 20: 601–602
   Google Scholar
• Koh C.L.S., Anandakumar C., Montan S., Ratnam S. S. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in preeclampsia. Gynecologic and Obstetric Investigation 1993; 35: 214–221
   PubMed Web of Science ®Google Scholar
• Lubbe W. F., Walker E. B. Chorea gravidarum associated with circulating lupus anticoagulant; successful outcome of pregnancy with prednisolone and aspirin therapy. Case report. British Journal of Obstetrics and Gynaecology 1983; 90: 487–490
   PubMedGoogle Scholar
• Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983; 1: 1361–1363
   PubMed Web of Science ®Google Scholar
• Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Lupus anticoagulant in pregnancy. British Journal of Obstetrics and Gynaecology 1984; 91: 357–363
   PubMedGoogle Scholar
• Mackinnon S., Walker I. D., Davidson J. F., Walker J. J. Plasma fibrinolysis during and after childbirth. British Journal of Haematology 1987; 65: 339–342
   Google Scholar
• Moroz L. A., MacLean L. D., Langleben D. Abnormalities in the cellular phase of blood fibrinolytic activity in systemic lupus erythematosus and venous thromboembolism. Thrombosis Research 1986; 43: 595–602
   Google Scholar
• Mueh J. R., Herbst K. D., Rapaport S. I. Thrombosis in patients with the lupus anticoagulant. Annals of Internal Medicine 1980; 92: 156–159
   PubMed Web of Science ®Google Scholar
• Nilsson I. M., Ljunger H., Tengbom L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. British Medical Journal 1985; 290: 1453–1455
   PubMedGoogle Scholar
• Stalder M., Hauert J., Keuithof E.K.O., Bachmann F. Release of vascular plasminogen activator (v–PA) after venous stasis: electrophoretic–zymo-graphic analysis of free and complexed V–PA. British Journal of Haematology 1985; 61: 169–176
   Google Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Tsakiris D. A., Marbet G. A., Makris P. E., Settas L., Duckert F. Impaired fibrinolysis as an essential contribution to thrombosis in patients with lupus anticoagulant. Thrombosis and Haemostasis 1989; 61: 175–177
   PubMedGoogle Scholar